These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 31177861)

  • 1. Chikungunya virus drug discovery: still a long way to go?
    Pérez-Pérez MJ; Delang L; Ng LFP; Priego EM
    Expert Opin Drug Discov; 2019 Sep; 14(9):855-866. PubMed ID: 31177861
    [No Abstract]   [Full Text] [Related]  

  • 2. Computer-Aided Structure Based Drug Design Approaches for the Discovery of New Anti-CHIKV Agents.
    Jadav SS; Sinha BN; Hilgenfeld R; Jayaprakash V
    Curr Comput Aided Drug Des; 2017 Nov; 13(4):346-361. PubMed ID: 28294048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spectrum of candidate molecules against Chikungunya virus - an insight into the antiviral screening platforms.
    Bhat SM; Mudgal PP; N S; Arunkumar G
    Expert Rev Anti Infect Ther; 2019 Apr; 17(4):243-264. PubMed ID: 30889372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of berberine, abamectin and ivermectin as antivirals against chikungunya and other alphaviruses.
    Varghese FS; Kaukinen P; Gläsker S; Bespalov M; Hanski L; Wennerberg K; Kümmerer BM; Ahola T
    Antiviral Res; 2016 Feb; 126():117-24. PubMed ID: 26752081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antivirals against the Chikungunya Virus.
    Battisti V; Urban E; Langer T
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral therapeutics for chikungunya virus.
    Ghildiyal R; Gabrani R
    Expert Opin Ther Pat; 2020 Jun; 30(6):467-480. PubMed ID: 32249636
    [No Abstract]   [Full Text] [Related]  

  • 7. Current Strategies for Inhibition of Chikungunya Infection.
    Subudhi BB; Chattopadhyay S; Mishra P; Kumar A
    Viruses; 2018 May; 10(5):. PubMed ID: 29751486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of a novel antiviral agent targeting the nonstructural protein 4 (nsP4) of chikungunya virus.
    Wada Y; Orba Y; Sasaki M; Kobayashi S; Carr MJ; Nobori H; Sato A; Hall WW; Sawa H
    Virology; 2017 May; 505():102-112. PubMed ID: 28236746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond Members of the
    Ferreira AC; Reis PA; de Freitas CS; Sacramento CQ; Villas Bôas Hoelz L; Bastos MM; Mattos M; Rocha N; Gomes de Azevedo Quintanilha I; da Silva Gouveia Pedrosa C; Rocha Quintino Souza L; Correia Loiola E; Trindade P; Rangel Vieira Y; Barbosa-Lima G; de Castro Faria Neto HC; Boechat N; Rehen SK; Brüning K; Bozza FA; Bozza PT; Souza TML
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30455237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral activities of niclosamide and nitazoxanide against chikungunya virus entry and transmission.
    Wang YM; Lu JW; Lin CC; Chin YF; Wu TY; Lin LI; Lai ZZ; Kuo SC; Ho YJ
    Antiviral Res; 2016 Nov; 135():81-90. PubMed ID: 27742486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationship study of arbidol derivatives as inhibitors of chikungunya virus replication.
    Di Mola A; Peduto A; La Gatta A; Delang L; Pastorino B; Neyts J; Leyssen P; de Rosa M; Filosa R
    Bioorg Med Chem; 2014 Nov; 22(21):6014-25. PubMed ID: 25282648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chikungunya virus infections: time to act, time to treat.
    Abdelnabi R; Neyts J; Delang L
    Curr Opin Virol; 2017 Jun; 24():25-30. PubMed ID: 28414993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral activity of nobiletin against chikungunya virus in vitro.
    Lin SC; Chen MC; Li S; Lin CC; Wang TT
    Antivir Ther; 2017; 22(8):689-697. PubMed ID: 28406093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Highly Selective Antivirals for Chikungunya Virus identified from the Screening of a Drug-Like Compound Library.
    Castro EF; Álvarez DE
    Curr Microbiol; 2024 Sep; 81(10):343. PubMed ID: 39227496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Chikungunya virus by computational approaches: from viral biology to the development of therapeutic strategies.
    Rabelo VW; Paixão ICNP; Abreu PA
    Expert Opin Ther Targets; 2020 Jan; 24(1):63-78. PubMed ID: 31914351
    [No Abstract]   [Full Text] [Related]  

  • 16. Antagonism of the Sodium-Potassium ATPase Impairs Chikungunya Virus Infection.
    Ashbrook AW; Lentscher AJ; Zamora PF; Silva LA; May NA; Bauer JA; Morrison TE; Dermody TS
    mBio; 2016 May; 7(3):. PubMed ID: 27222471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral Strategies Against Chikungunya Virus.
    Abdelnabi R; Neyts J; Delang L
    Methods Mol Biol; 2016; 1426():243-53. PubMed ID: 27233277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antivirals against Chikungunya Virus: Is the Solution in Nature?
    Martins DOS; Santos IA; de Oliveira DM; Grosche VR; Jardim ACG
    Viruses; 2020 Feb; 12(3):. PubMed ID: 32121393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chikungunya virus: an update on antiviral development and challenges.
    Kaur P; Chu JJ
    Drug Discov Today; 2013 Oct; 18(19-20):969-83. PubMed ID: 23684571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Micafungin is a novel anti-viral agent of chikungunya virus through multiple mechanisms.
    Ho YJ; Liu FC; Yeh CT; Yang CM; Lin CC; Lin TY; Hsieh PS; Hu MK; Gong Z; Lu JW
    Antiviral Res; 2018 Nov; 159():134-142. PubMed ID: 30300716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.